Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling-Reference-Cited by-同舟云学术

Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling

Published:2021-12-04 Issue:1 Volume:36 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Marchianò Silvia¹^ORCID,Biagioli Michele¹,Roselli Rosalinda²,Zampella Angela²,Di Giorgio Cristina¹,Bordoni Martina¹,Bellini Rachele¹,Morretta Elva³,Monti Maria Chiara³,Distrutti Eleonora⁴,Fiorucci Stefano¹^ORCID

Affiliation:

1. Department of Medicine and Surgery University of Perugia Perugia Italy

2. Department of Pharmacy University of Naples Federico II Naples Italy

3. Department of Pharmacy University of Salerno Salerno Italy

4. Azienda Ospedaliera di Perugia Perugia Italy

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202101397R

Reference97 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

3. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

4. Future trends in the treatment of non-alcoholic steatohepatitis

5. Mechanisms of NAFLD development and therapeutic strategies

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins in Chronic Liver Disease: Review of the Literature and Future Role;Seminars in Liver Disease;2024-05

2. A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action;Molecules;2024-04-19

3. The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease;Hepatology Communications;2023-12-15

4. Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease;Journal of the American Heart Association;2023-12-05

5. Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease;Biochemical Pharmacology;2023-12